Ascendis Pharma A ASND Insider Ownership

NASDAQ ASND
$268.50 -2.62 (-0.97%)
As of: Sep 4, 2026 · 11:48 AM EDT

Insider Holdings by Owner

4.37K Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
share count not reported for this filer set
Shares Held by Insiders
7.27K
filed for Sep 2026
+37.97% QoQ
Shares Outstanding
not reported
Direct Holdings
7.27K
Indirect: 0
Net Shares Traded (QoQ)
+2.00K
net buying in Sep 2026
Insiders Holding Shares
1
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest
Average ownership
Peak ownership

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter
Net over range
Buying quarters

Insider Ownership Summary

Quarter ending 30 Sep, 2026

As of August 29, 2026, the three largest insider holders of ASND are Scott Thomas Smith (Evp Chief Financial Officer, 4.37K shares).

Form 4 Holdings

Insiders Holding ASND

Insiders 1
Shares held 4.37K
Of outstanding
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Scott Thomas Smith Evp Chief Financial Officer 4,367 0 4,367 100.0% 02 Jun, 2026

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

3 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
02 Jun, 2026 Scott Thomas Smith Evp Chief Financial Officer Acquired P 100 $219.00 $21.90K 4,367 Direct
29 May, 2026 Scott Thomas Smith Evp Chief Financial Officer Acquired P 250 $223.32 $55.83K 4,267 Direct
11 May, 2026 Flemming Steen Jensen Officer Disposed S 19,460 $238.49 $4.64Mn 0 Direct